Final answer:
The appropriate duration of anti-platelet therapy for patients with a drug-eluting stent is typically 6 to 12 months.
Step-by-step explanation:
The appropriate duration of anti-platelet therapy for patients who have received a drug-eluting stent depends on various factors such as the type of stent, the patient's risk factors, and the individual's bleeding risk. Generally, it is recommended that patients take dual anti-platelet therapy (DAPT) with clopidogrel and aspirin for at least 6 to 12 months after receiving a drug-eluting stent.